文献速递前列腺增生与排尿功能障碍

cAMP依赖性调节RhoA/Rho激酶可减轻新型小鼠实验模型中的逼尿肌过度活动

cAMP-dependent regulation of RhoA/Rho-kinase attenuates detrusor overactivity in a novel mouse experimental model.
PubMed 文献 · BJU Int · 2017-04-11

在缺乏S-亚硝基谷胱甘肽还原酶(GSNOR)的小鼠模型中,GSNOR-/-小鼠的排尿和非排尿收缩频率显著高于野生型,且RhoA/Rho激酶通路上调。腹腔注射cAMP激活剂colforsin(1 mg/kg)7天可逆转这些生理和分子异常。本研究描述了一种新型逼尿肌过度活动模型,并提示其可能的治疗基础。

要点

  • GSNOR-/-小鼠排尿和非排尿收缩频率显著高于野生型(P<0.05)。
  • Colforsin使GSNOR-/-小鼠的上述异常正常化。
  • GSNOR-/-小鼠膀胱P-MYPT-1表达显著升高,colforsin可逆转。

核心结论

  • 去亚硝基化受损与逼尿肌过度活动相关,后者与RhoA/Rho激酶信号上调有关。
  • Colforsin可逆转生理和分子异常,本研究为逼尿肌过度活动的治疗提供了可能依据。

研究设计与样本

  • GSNOR缺陷(GSNOR-/-)小鼠(n=30)与野生型(WT)小鼠(n=26)分别接受cAMP激活剂colforsin(1 mg/kg)或溶媒腹腔注射7天。
  • 进行膀胱测压研究或膀胱标本分子分析,评估膀胱功能指标及调节逼尿肌松弛(一氧化氮合酶通路)或收缩(RhoA/Rho激酶通路)和氧化应激的蛋白表达水平。
  • 统计分析采用Student t检验和单因素方差分析。

主要发现

  • GSNOR-/-小鼠排尿和非排尿收缩频率显著高于WT小鼠(P<0.05),Cohen效应量d分别为1.82和2.52。
  • Colforsin使上述异常正常化,Cohen效应量d分别为1.85和1.28。
  • Western blot分析显示GSNOR-/-小鼠膀胱磷酸化肌球蛋白磷酸酶靶亚基1(P-MYPT-1)表达显著升高(P<0.05),反映RhoA/Rho激酶通路上调,colforsin治疗可逆转。
  • GSNOR-/-小鼠膀胱gp91phox表达水平较高(P<0.05),colforsin治疗后无显著变化。
  • 神经元型和内皮型一氧化氮合酶分别在Ser-1412和Ser-1177位点的磷酸化在GSNOR-/-与WT小鼠膀胱间无差异,且不受colforsin治疗影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate detrusor function and cAMP activation as a possible target for detrusor overactivity in an experimental model lacking a key denitrosylation enzyme, S-nitrosoglutathione reductase (GSNOR). MATERIALS AND METHODS: GSNOR-deficient (GSNOR-/- ) (n = 30) and wild-type (WT) mice (n = 26) were treated for 7 days with the cAMP activator, colforsin (1 mg/kg), or vehicle intraperitoneally. Cystometric studies or molecular analyses of bladder specimens were performed. Bladder function indices and expression levels of proteins that regulate detrusor relaxation (nitric oxide synthase pathway) or contraction (RhoA/Rho-kinase pathway) and oxidative stress were assessed. For statistical analysis the Student's t-test and one-way analysis of variance were used. RESULTS: GSNOR-/- mice had significantly higher (P < 0.05) voiding and non-voiding contraction frequencies compared to WT mice (Cohen's effect size values d = 1.82 and 2.52, respectively). Colforsin normalised these abnormalities (Cohen's effect size values d = 1.85 and 1.28, respectively). Western blot analyses showed an up-regulation of the RhoA/Rho-kinase pathway reflected by significantly higher (P < 0.05) phosphorylated myosin phosphatase target subunit 1 (P-MYPT-1) expression in GSNOR-/- mouse bladders, which was reversed by colforsin treatment. There was a higher level (P < 0.05) of gp91phox expression in the bladders of GSNOR-/- mice without significant change after colforsin treatment. Neuronal and endothelial nitric oxide synthase phosphorylation on Ser-1412 and Ser-1177, respectively, did not differ between GSNOR-/- and WT mouse bladders irrespective of colforsin treatment. CONCLUSION: Impaired denitrosylation is associated with detrusor overactivity, which is linked with upregulated RhoA/Rho-kinase signalling. Colforsin reverses physiological and molecular abnormalities. This study describes a novel model of detrusor overactivity and suggests a possible basis for its treatment.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Akakpo W, Musicki B, Burnett AL, et al. cAMP-dependent regulation of RhoA/Rho-kinase attenuates detrusor overactivity in a novel mouse experimental model. BJU Int. 2017. PMID: 28303627. doi:10.1111/bju.13847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。